Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24)
- 15 December 2005
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 71 (4) , 426-440
- https://doi.org/10.1016/j.bcp.2005.11.009
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Recent Developments in the Field of Tumor-Inhibiting Metal ComplexesCurrent Pharmaceutical Design, 2003
- Synthesis, characterization and DNA-binding properties of La(III) complex of chrysinJournal of Inorganic Biochemistry, 2003
- La3+, Gd3+ and Yb3+ induced changes in mitochondrial structure, membrane permeability, cytochrome c release and intracellular ROS levelChemico-Biological Interactions, 2003
- EFFECTS OF RARE EARTH COMPOUNDS ON GROWTH AND APOPTOSIS OF LEUKEMIC CELL LINESIn Vitro Cellular & Developmental Biology – Animal, 2002
- Spectroscopy, cytotoxicity and DNA-binding of the lanthanum(III) complex of an l-valine derivative of 1,10-phenanthrolineJournal of Inorganic Biochemistry, 2001
- Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cellsInternational Journal of Cancer, 2001
- Morphology and proliferation of B16 melanoma cells in the presence of lanthanoid and Al3+ ionsBioMetals, 1998
- 1,10-Phenanthroline: a versatile ligandChemical Society Reviews, 1994
- Competence induction by PDGF requires sustained calcium influx by a mechanism distinct from storage-dependent calcium influxCell Calcium, 1993
- Effects of gallium and lanthanum on experimental tumor growthPublished by Elsevier ,1979